Related Experiment Video
Updated: Jul 22, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Lutein Induces Reactive Oxygen Species-Mediated Apoptosis in Gastric Cancer AGS Cells via NADPH Oxidase Activation
Ju Won Eom1, Joo Weon Lim1, Hyeyoung Kim1
1Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea.
Abstract:
Disruption of apoptosis leads to cancer cell progression; thus, anticancer agents target apoptosis of cancer cells. Reactive oxygen species (ROS) induce apoptosis by activating caspases and caspase-dependent DNase, leading to DNA fragmentation. ROS increase the expression of apoptotic protein Bax, which is mediated by activation of nuclear factor-κB (NF--κB). Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is an important source of endogenous ROS, and its activation is involved in apoptosis. Lutein, an oxygenated carotenoid and known antioxidant, is abundant in leafy dark green vegetables, such as spinach and kale, and in yellow-colored foods, such as corn and egg yolk. High amounts of lutein increase ROS levels and exhibit anticancer activity. However, its anticancer mechanism remains unclear. This study aimed to determine whether lutein activates NADPH oxidase to produce ROS and induce apoptosis in gastric cancer AGS cells. Lutein increased ROS levels and promoted the activation of NADPH oxidase by increasing the translocation of NADPH oxidase subunit p47 phox to the cell membrane. It increased NF-κB activation and apoptotic indices, such as Bax, caspase-3 cleavage, and DNA fragmentation, and decreased Bcl-2, cell viability, and colony formation in AGS cells. The specific NADPH oxidase inhibitor ML171, and the known antioxidant N-acetyl cysteine reversed lutein-induced cell death, DNA fragmentation, and NF-κB DNA-binding activity in AGS cells. These results suggest that lutein-induced ROS production is dependent on NADPH oxidase, which mediates NF-κB activation and apoptosis in gastric cancer AGS cells. Therefore, lutein supplementation may be beneficial for increasing ROS-mediated apoptosis in gastric cancer cells.
Insights
Lutein boosts reactive oxygen species (ROS) production in gastric cancer cells by activating NADPH oxidase. This process triggers apoptosis, offering a potential therapeutic strategy for gastric cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Apoptosis disruption drives cancer progression, making it a key target for anticancer therapies.
- Reactive oxygen species (ROS) are crucial inducers of apoptosis, activating caspases and leading to DNA fragmentation.
- Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a significant endogenous source of ROS involved in apoptosis.
Purpose of the Study:
- To investigate if lutein activates NADPH oxidase to generate ROS and induce apoptosis in gastric cancer AGS cells.
- To elucidate the molecular mechanisms underlying lutein's anticancer effects in gastric cancer.
Main Methods:
- Assessed ROS levels and NADPH oxidase activation in AGS cells treated with lutein.
- Examined the translocation of NADPH oxidase subunit p47phox, NF-κB activation, and apoptotic markers (Bax, caspase-3 cleavage, DNA fragmentation, Bcl-2).
- Utilized a specific NADPH oxidase inhibitor (ML171) and an antioxidant (N-acetyl cysteine) to validate lutein's mechanism.
Main Results:
- Lutein significantly increased ROS levels and activated NADPH oxidase by promoting p47phox translocation.
- Lutein enhanced NF-κB activation, increased apoptotic indices (Bax, caspase-3 cleavage, DNA fragmentation), and decreased Bcl-2 expression and cell viability.
- Inhibition of NADPH oxidase or ROS scavenging reversed lutein-induced apoptosis and NF-κB activity.
Conclusions:
- Lutein-induced ROS production in gastric cancer cells is mediated by NADPH oxidase activation.
- This ROS production activates NF-κB signaling, leading to apoptosis.
- Lutein demonstrates potential as a therapeutic agent for enhancing ROS-mediated apoptosis in gastric cancer.

